Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 8, 2025
AgEagle Aerial Systems Secures Additional Sale of eBee VISION Drones to the British Antarctic Survey
GlobeNewswire
·
May 8, 2025
World leader in polar science and polar operations research to use additional drones to enhance its Antarctic conservation, research, and wildlife preservation efforts WICHITA, Kan., May 08, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS …
Delinea Hires Alex Thurber as Senior Vice President of Global Channels, Further Strengthening Its Partner Strategy
GlobeNewswire
·
May 8, 2025
SAN FRANCISCO, May 08, 2025 (GLOBE NEWSWIRE) -- Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, today announced the leadership appointment of Alex Thurber as Senior Vice President of …
Senti Bio Releases Mechanism of Action Video for First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202
GlobeNewswire
·
May 8, 2025
Access video here SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its …
Bitget to list Shardeum adding it to Spot Trading
Chainwire
·
May 8, 2025
Victoria, Seychelles, May 8th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Shardeum, adding it to spot trading. Shardeum is an EVM-based, autoscaling L1 blockchain that uses dynamic state …
Bitget Lists Redacted (RDAC) in the Innovation and Web3 Zone
Chainwire
·
May 8, 2025
Victoria, Seychelles, May 8th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Redacted (RDAC) on its platform. Trading for RDAC/USDT will commence on 13 May, 10:00 (UTC) with deposit available now …
Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
GlobeNewswire
·
May 8, 2025
CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently available clinical data from its key clinical programs and a challenging fundraising …
HepaRegeniX Scientific Founder Covers HRX-215 Development and Clincial Data in Plenary at the European Association for the Study of the Liver Congress 2025
GlobeNewswire
·
May 8, 2025
Prof. Lars Zender’s featured talk described HepaRegeniX’s lead candidate and its potential in increasing liver regeneration, from initial target discovery and drug development towards Phase Ia clinical trial results Tuebingen, Germany, May 8, 2025 – …
ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 8, 2025
Following announcement of prioritized development strategy for evorpacept in combination with anti-cancer antibodies at R…
Intent IQ Achieves SOC 2 Compliance, Reinforcing Enterprise-Grade Trust in Data Security and Privacy
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Intent IQ, a leading provider of identity resolution and data technology, today announced that it has successfully achieved SOC 2 compliance, a critical milestone that underscores the company’s commitment to …
Brag House Holdings, Inc. Files Form 10-K and Reaffirms Strategic Vision for Gen Z Engagement Through Gaming
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”), a media-tech company at the intersection of gaming, college sports, and digital brand engagement, today announced the filing of its Annual …
ZenaTech’s ZenaDrone Tests Proprietary Camera Enabling IQ Nano Drone Swarms for US Defense Applications and Blue UAS Submission
GlobeNewswire
·
May 8, 2025
VANCOUVER, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS, and …
Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to treating the core symptoms of autism spectrum disorder (ASD), today announced positive Phase 2 results for L1-79, presented at the …
NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations
GlobeNewswire
·
May 8, 2025
New funding from Dr. Song augments $3.0 million in funding advances from AlpineBrook Capital in 2025 above and beyond the $5.5 million proceeds and additional $4 million commitments in previously-disclosed AlpineBrook convertible notes. SANTA ANA, Calif., …
IMUNON Announces First Site Initiated for Pivotal Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
GlobeNewswire
·
May 8, 2025
Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in women with advanced ovarian …
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 8, 2025
-- Revenues increase 22% year over year driven by 90% growth in Zola® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 ( …
BairesDev Wins Stevie Awards for AI Innovation, Executive Leadership, and Talent Development
GlobeNewswire
·
May 8, 2025
MOUNTAIN VIEW, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- BairesDev®, an award-winning nearshore software development company, has been recognized with three Silver Stevie® Awards at the 23rd Annual American Business Awards®, celebrating the company’s …
Aligos Therapeutics Presents Positive Data at the EASL Congress 2025
GlobeNewswire
·
May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting
GlobeNewswire
·
May 8, 2025
PRINCETON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious …
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
GlobeNewswire
·
May 8, 2025
IND clearance and initiation of global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory myopathies and systemic sclerosis First trial to explore an allogeneic cell therapy in …
ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
GlobeNewswire
·
May 8, 2025
Approximately 15 million USD Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases Oryzon will explore Aggression in specific subsets of Autism Spectrum Disorder (ASD) to expand the precision …